Skip to main content

Table 1 Baseline characteristics of two groups

From: Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection

Variables

Postoperative adjuvant chemotherapy

X2

P

Absence (n = 84)

Presence(n = 64)

Gender

 male

43

40

  

 female

41

24

1.886

0.170

Age (years)

  < =55

19

22

  

  > 55

65

42

2.507

0.113

Tumor differentiation

 low

18

5

  

 moderate

61

56

  

 high

5

3

5.458

0.065

Tumor size (cm)

  > 5 cm

37

24

  

  < =5 cm

47

40

0.643

0.423

Microvascular.invasion

 absence

60

43

  

 presence

24

21

0.309

0.578

Nerve invasion

 absence

68

56

  

 presence

16

8

1.146

0.284

Preoperative Ca19–9(u/ml)

  ≤ 37.00u/ml

37

27

  

  > 37.00u/ml

47

37

0.051

0.821

Preoperative TBIL (umol/L)

  ≤ 17.1 umol/L

71

59

  

  > 17.1 umol/L

13

5

1.997

0.158

HbsAg

 positive

48

33

  

 negative

36

31

0.457

0.499

Surgical type

 Open surgery

61

44

  

 laparoscopic surgery

23

20

0.264

0.608

Type of liver resection

 local liver resection

25

26

  

 left lateral lobe resection

17

14

  

 left hemihepatectomy

16

9

  

 right hemihepatectomy

11

9

  

 Other types of liver resection

15

6

3.692

.449

Postoperative molecular targeted drug

 absence

67

49

  

 presence

17

15

0.219

0.639